DIVI S LABORATORIES LTD vs Ind-Swift Ltd

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and Ind-Swift Ltd (INDSWFTLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs INDSWFTLTD on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth10
  • Size & financial health30
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.49
P/E ratio
0.30
10.62
P/B ratio
0.00
0.33%
Dividend yield
0.00%
₹96.73
EPS
₹52.30

Profitability

DIVISLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
0.00%
22.00%
Return on capital
12.00%
33.00%
EBITDA margin
4.50%
24.32%
Net margin
54.95%

Growth

DIVISLAB takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
8.97%
12.10%
Profit CAGR (3Y) even

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.43L Cr
Market cap
₹0 Cr
₹10,560 Cr
Revenue
₹515 Cr
₹2,568 Cr
Net profit
₹283 Cr
0.00
Debt / equity even
0.00
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Ind-Swift Ltd
  • + ["Company has delivered good profit growth of 18.2% CAGR over last 5 years"]
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 9.35% over past five years.", "Contingent liabilities of Rs.72.4 Cr.", "Earnings include an other income of Rs.328 Cr."]
DIVI S LABORATORIES LTD full analysis Ind-Swift Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs INDSWFTLTD: Share Price, Valuation & Which to Buy | DocStoX